Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Anna King is active.

Publication


Featured researches published by Anna King.


The Lancet | 1988

EPIDEMIC MULTIRESISTANT ESCHERICHIA COLI INFECTION IN WEST LAMBETH HEALTH DISTRICT

Ian Phillips; Anna King; Bernard Rowe; Susannah J. Eykyn; W. R. Gransden; JenniferA. Frost; RogerJ. Gross

A year-long outbreak of multiresistant Escherichia coli K52 H1, predominantly serogroup O15, is reported from south east London. Most patients had urinary tract infections, some with septicaemia; but some cases of septicaemia were associated with pneumonia, meningitis, and endocarditis--unusual infections for E coli. 3 of these patients died. The organism was acquired in the community, and its source is still being investigated.


The Lancet | 1974

Control of respirator-associated infection due to Pseudomonas aeruginosa.

Ian Phillips; Stephen Jenkins; Anna King; Geoffrey Spencer

Abstract The efficacy of nebulised alcohol and formaldehyde in a chamber (Aseptor) specially designed for disinfecting automatic lung ventilators has been studied. Bacteriological examination of the respirators after disinfection, and a study of the epidemiology of Pseudomonas aeruginosa infection in an intensive-care unit (I.C.U.), suggest that the alcohol method did not disinfect the respirators but that the formaldehyde method was effective, bringing to an end endemic Ps. aeruginosa infection and contamination in the I.C.U.


Journal of Antimicrobial Chemotherapy | 1990

Importation of organisms producing broad-spectrum SHV-group β-lactamases into the United Kingdom

Kevin Shannon; Anna King; Ian Phillips; M. H. Nicolas; Alain Philippon


Clinical Microbiology and Infection | 2002

Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin

Anna King; T. Bathgate; Ian Phillips


Clinical Infectious Diseases | 1988

Comparative Activity of the 4-Quinolones

Ian Phillips; Anna King


Clinical Microbiology and Infection | 1999

Evaluation of the Rapid ID 32A system for identification of anaerobic Gram-negative bacilli, excluding the Bacteroides fragilis group

Julie Downes; Anna King; Jeremy Hardie; Ian Phillips


Journal of Antimicrobial Chemotherapy | 1980

The in nitro antibacterial activity of cefotaxime compared with that of cefuroxime and cefoxitin

Anna King; Christine Warren; Kevin Shannon; Ian Phillips


Journal of Antimicrobial Chemotherapy | 1981

Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.

Ian Phillips; Christine Warren; Kevin Shannon; Anna King; David Hanslo


Journal of Antimicrobial Chemotherapy | 1983

Cefotetan: in-vitro antibacterial activity and susceptibility to beta-lactamases.

Ian Phillips; Anna King; Kevin Shannon; Christine Warren


Journal of Antimicrobial Chemotherapy | 1981

Sch 29482: in-vitro antibacterial activity and susceptibility to beta-lactamases.

Ian Phillips; Anna King; Kevin Shannon; Christine Warren

Collaboration


Dive into the Anna King's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge